Chapter 22 Drugs Used to Treat Dyslipidemias

$2.50

Pay And Download The Complete Chapter Questions And Answers

Chapter 22  Drugs Used to Treat Dyslipidemias

 

 

Complete Chapter Questions And Answers
 

Sample Questions

 

MULTIPLE CHOICE

1. Which lipoprotein contributes to the development of atherosclerosis?
A.
Chylomicrons
B.
VLDL
C.
LDL-C
D.
HDL-C

ANS: C

Feedback
A
Chylomicrons are intermediate-density lipoproteins.
B
Very low-density lipoproteins are not as important in the development of atherosclerosis as low-density lipoproteins.
C
The probability that atherosclerosis will develop is related directly to the concentration of LDL-C.
D
High-density lipoproteins do not contribute to the development of atherosclerosis.

DIF: Cognitive Level: Comprehension REF: 341
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity

2. The nurse is preparing medications for a patient. When is the best time for the nurse to administer lovastatin (Mevacor)?
A.
2 hours after breakfast
B.
During the patient’s dinner
C.
1 hour before breakfast
D.
30 minutes before lunch

ANS: B

Feedback
A
It is not recommended that lovastatin be taken after food but while eating to enhance absorption.
B
Lovastatin should be administered with food to enhance absorption, and in the evening, because this is when the production of cholesterol is at its highest.
C
Taking the medication an hour before eating would not benefit the patient or enhance absorption.
D
Taking the medication a half-hour before eating would not benefit the patient or enhance absorption.

DIF: Cognitive Level: Application REF: 347
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Physiological Integrity

3. The nurse has completed an admitting patient history and notes the patient’s current medications to be simvastatin (Zocor) and warfarin (Coumadin). What is the result of the interaction of these drugs?
A.
Abdominal distention
B.
Increased INR
C.
Low serum level of simvastatin
D.
Hypertension

ANS: B

Feedback
A
Abdominal distention does not occur with the combined therapy of simvastatin and warfarin.
B
The combined therapy of simvastatin and warfarin may prolong the patient’s INR. Additional nursing assessments would include monitoring for possible overcoagulation and bleeding.
C
A low serum level of simvastatin does not occur with the combined therapy of simvastatin and warfarin.
D
Increased blood pressure is not a complication of combining simvastatin and warfarin therapy.

 

DIF: Cognitive Level: Application REF: 349
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Physiological Integrity

4. Which deficiency may develop in patients taking cholestyramine?
A.
Potassium deficiency
B.
Sodium deficiency
C.
Vitamin K deficiency
D.
Hydrochloric acid deficiency

ANS: C

Feedback
A
Cholestyramine does not affect electrolyte levels.
B
Cholestyramine does not affect electrolyte levels.
C
Patients on long-term bile acid–sequestering resin therapy may become deficient in fat-soluble vitamins (i.e., D, E, A, K).
D
Cholestyramine does not affect hydrochloric acid.

DIF: Cognitive Level: Knowledge REF: 344
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity

 

There are no reviews yet.

Add a review

Be the first to review “Chapter 22 Drugs Used to Treat Dyslipidemias”

Your email address will not be published. Required fields are marked *

Category: Tag:
Updating…
  • No products in the cart.